Vehicle-treated mice showed 1863 ± 379 μm2 CD31-immunoreactive areas per field, whereas IDR-E804-treated mice showed 703 ± 102 μm2 per field (Figure5), indicating that IDR-E804 significantly inhibited tumor angiogenesis and thereby prevented tumor growth. Here, PECAM1 is linked to neoplasm.